|
End-of-day quote
TEL AVIV STOCK EXCHANGE
29/10/2026
|
5-day change | 1st Jan Change | ||
| 1,762.00 ILa | +0.11% |
|
-4.03% | - |
| 07-14 | Rafa Laboratories Ltd. has completed an IPO in the amount of ILS 549.8718 million. | CI |
| 07-09 | Rafa Laboratories Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
TEL AVIV STOCK EXCHANGEILa
| Markets | Quality | ||
|---|---|---|---|
TEL AVIV STOCK EXCHANGE
| RAFA | End-of-day quote | |
TEL AVIV STOCK EXCHANGE
| RAFA | Delayed |
| 1 day | +0.11% | ||
| 1 week | -4.03% | ||
| Current month | -2.71% | ||
| 1 month | -1.29% | ||
| 3 months | +10.33% |
| 1 week | 1,671 |  | 1,865 |
| 1 month | 1,577 | | 1,868 |
| Current year | 1,401 | | 1,999 |
| 1 year | 1,401 | | 1,999 |
| 3 years | 1,401 | | 1,999 |
| 5 years | 1,401 | | 1,999 |
| 10 years | 1,401 | | 1,999 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ido Leshem
CEO | Chief Executive Officer | 50 | 01/01/2024 |
Gabi Hazan
COO | Chief Operating Officer | 58 | 01/01/2007 |
Yael Paula Tomer
CTO | Chief Tech/Sci/R&D Officer | 56 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Gillon Beck
BRD | Director/Board Member | 64 | 31/12/2020 |
Abraham Dadon
BRD | Director/Board Member | 70 | 27/05/2026 |
Amir Levin
BRD | Director/Board Member | 60 | 26/06/2007 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.11% | -4.03% | - | - | 555M | |
| +6.63% | +5.13% | +68.86% | +145.20% | 1,224B | |
| +1.53% | +2.84% | +47.48% | +89.01% | 662B | |
| +1.68% | +1.96% | +29.16% | +109.31% | 514B | |
| +0.51% | +3.15% | +54.07% | +67.09% | 388B | |
| +3.83% | -0.62% | +69.01% | +42.32% | 361B | |
| +0.91% | +4.20% | +34.89% | +57.60% | 302B | |
| +3.92% | +5.74% | +8.08% | +32.71% | 271B | |
| +1.97% | +3.01% | +57.91% | +76.14% | 249B | |
| +4.03% | +5.36% | +39.76% | +116.14% | 205B | |
| Average | +1.82% | +1.93% | +45.47% | +81.73% | 417.74B | |
| Weighted average by Cap. | +1.75% | +3.04% | +50.74% | +96.54% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 420M 0 135M 121M 112M 101M 189M 12.86B 192M 1.33B 531M 6.73B 507M 496M 21.32B | 418M 0 135M 120M 111M 101M 188M 12.81B 191M 1.33B 529M 6.7B 505M 494M 21.23B |
| Net income | 99.43M 0 31.96M 28.63M 26.41M 23.9M 44.69M 3.04B 45.42M 315M 126M 1.59B 120M 117M 5.05B | 100M 0 32.26M 28.89M 26.65M 24.12M 45.1M 3.07B 45.83M 318M 127M 1.61B 121M 118M 5.09B |
| Net Debt | - | - |
Employees
257
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/10/26 | ILA 1,762.00 | +0.11% | 5,431 |
| 28/10/26 | ILA 1,760.00 | -5.12% | 12,581 |
| 26/10/26 | ILA 1,855.00 | +0.05% | 37,374 |
| 23/10/26 | ILA 1,854.00 | +0.98% | 1,760 |
| 22/10/26 | ILA 1,836.00 | +1.49% | 24,167 |
- Stock Market
- Stocks
- RAFA Stock
Select your edition
All financial news and data tailored to specific country editions
